Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Arrhythmias, Cardiac × Population Groups × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Small Cell Lung Carcinoma 1 Neoplasms 1 Lung Neoplasms 1 Heart Failure 1 Carcinoma, Non-Small-Cell Lung 1 Arrhythmias, Cardiac 1 Anemia 1

Interventions

Population Groups 1 Control Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06092606 2023-10-23

A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients

Monyan Pharmaceutical (Shanghai) Co., Ltd.

Phase 2 Unknown

Arrhythmias, Cardiac, Heart Failure, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡